<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8507085</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7839</journal-id>
<journal-id journal-id-type="nlm-ta">Trends Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Trends Genet.</journal-id>
<journal-title-group>
<journal-title>Trends in genetics : TIG</journal-title>
</journal-title-group>
<issn pub-type="ppub">0168-9525</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30466729</article-id>
<article-id pub-id-type="pmc">6339821</article-id>
<article-id pub-id-type="doi">10.1016/j.tig.2018.10.002</article-id>
<article-id pub-id-type="manuscript">NIHMS1510341</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>RNA splicing and disease: animal models to therapies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Montes</surname>
<given-names>Matías</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanford</surname>
<given-names>Brianne L.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Comiskey</surname>
<given-names>Daniel F.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chandler</surname>
<given-names>Dawn S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Molecular, Cellular and Developmental Biology Graduate Program and The Center for RNA Biology, The Ohio State University, Columbus, Ohio</aff>
<aff id="A2"><label>2</label>Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio</aff>
<aff id="A3"><label>3</label>Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Correspondence: <email>chandler.135@osu.edu</email> (D.S. Chandler)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>35</volume>
<issue>1</issue>
<fpage>68</fpage>
<lpage>87</lpage>
<!--elocation-id from pubmed: 10.1016/j.tig.2018.10.002-->
<abstract id="ABS1">
<p id="P1">Alternative splicing of pre-messenger RNA increases genetic diversity and recent studies estimate that most human multi-exon genes are alternatively spliced. If this process is not highly regulated and accurate, it leads to mis-splicing events which may result in proteins with altered function. A growing body of work has implicated mis-splicing events as contributing to a wide range of diseases including cancer, neurodegenerative diseases, and muscular dystrophies. Understanding the mechanisms that cause aberrant splicing events and how this leads to disease is vital for designing effective therapeutic strategies. This review focuses on advances in therapies targeting splicing and highlights the animal models developed to recapitulate disease phenotypes as a model for testing these therapies.</p>
</abstract>
<kwd-group>
<kwd>RNA splicing</kwd>
<kwd>disease</kwd>
<kwd>animal models</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>